Horse Chestnut Seeds Extract, HGC, Cream or Ointment

Pharmaceutical Licensing Product
Chemical for symptomatic treatment of RA, osteoarthritis, ankylosing spondylitis

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material&n...

Pharmaceutical Licensing Product
Chemical for urinary incontinence

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material  •  Licensee prepares dossier acc...

Pharmaceutical Licensing Product
Chemical for oral contraception (2nd generation)

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material  •  Licensee prepares ...

Pharmaceutical Licensing Product
Chemical for pain and inflammation

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material  •  Licensee prepares dossier ac...

Consumer Health Care Product Concept
Cholesterol control

Aenova offers broad expertise in the development of Consumer Health Care products:
• Thorough understanding of global and regional market needs  • Creation of new product concepts based on current and foreseen innovation trends...

Pharmaceutical Licensing Product
Chemical for diabetes type II

Aenova offers a broad range of pharmaceutical license products under the following license model: 
• Aenova provides and updates dossiers and scientific material    • Licensee prepares dossie...

Aenova publishes its 2020 Annual Report today. The report summarises the business and highlights for 2020 and gives insights into the company’s strategy.

Learn more about Aenova's 2020 achievements and milestones, as well as key events in each business unit

We make the advantages of continuous production available to you. That is why we have invested in our „Enterprise Concept“ and greatly increased production capacity.

Increased production capacity to over 10 billion tablets per year at Aenova Tittmoning࡟Investment of about € 25 million as one of the strategic growth projects
࡟More than 3,100 sqm large production building is being constructed
࡟With 700 employees, the Tittmoning site will produce 10 billion tablets for more than 100 customers on all continents

Your Partner for Conventional and Biologics Fill&FinishThe expansion of our Fill&Finish capacities is an investment in the future. Our completely new Fill&Finish suite at the Latina site enables the highest quality.

࡟Fully automated aseptic filling process multipurpose machine for vials/PFS products࡟Up to three additional filling lines with the chance to triple production volumes
࡟Capacity for 80 m vials or 180 m PFS per year

The World’s Leading Animal Health Partner at Your SideAenova offers over 20 years of experience and 9 approved manufacturing sites. This enables us to provide excellent end-to-end services from development to packaging for a wide range of medicines for companion animals and livestock.࡟Market leading capabilities across all dosage forms 
࡟A strategic partner for more than 16 of the Top 20 companies
࡟Regulatory compliance for products marketed in over 90 countries

Aenova ensures development and commercial manufacturing success. With our deep technical expertise and manufacturing know-how in a wide range of technologies, we are the one-stop CDMO for sterile injectables.࡟Wide range of capabilities including vial, ampoule and pre-filled syringe formats, lyophilized, powder filling and conventional liquid manufacturing
࡟Specialty production areas, including high volume, cytotoxic and small scale clinical trial material manufacturing solutions
࡟Regulatory compliance for products marketed worldwide, including Europe, North America and Asia

There is nothing that replaces experience when it comes to HPAPI handling- from product development to commercial supply. At Aenova we offer specialized, modern infrastructure and highly qualified experts for successful development and production of highest quality HPAPI products.
࡟HPAPI handling up to OEB 5
࡟Development and commercial supply for all solid dosage forms and sterile injectables
࡟Oncology and immunosuppressants, hormones and lowdosed HPAPIs

At Aenova, we are proud to be your trusted partner for full-service development and technology support throughout the product lifecycle.www.aenova-group.com࡟Decades of proven experience in drug formulation and product development 
࡟Highly skilled scientists and engineers complemented by a dedicated project management team
࡟Covering all relevant dosage forms incl. HPAPI handling, inhalation products and clinical trial management

As a market leader for softgel capsule development and manufacturing our customers benefit from our decades of experience. We dedicate our deep production process know-how and full range of technologies to get your challenging compounds to market faster.࡟On-time-delivery close to 100%
࡟One-stop shop from development to finished packed product supply
࡟State-of-the-art infrastructure ensures sustainability and business continuity

We go beyond manufacturing with a commitment to quality and reliability that is anchored in everything we do. Scientific expertise, innovative technology platforms and a strong customer focus make us the one-stop shop of choice.  ࡟ Contract development and manufacturing of all dosage forms and potency levels
࡟ Small to large scale production and specialized technologies 
࡟ Industry leading on-time delivery and quality 


Together, let’s go beyond manufacturing to enhance patients’ lives. 

On the company site of Dragenopharm Apotheker Püschl GmbH, member of the Aenova Group, a new production building is under construction.
The production capacity of the site can thus be increased to over 10 billion tablets per year.

The investment of about € 25 million lays the cornerstone for more than 100 new jobs and is part of further investment projects of the Aenova Group.

As a leading global contract manufacturer and development service provider with 15 production sites in Europe and the USA, we offer extensive capabilities for Steriles, Semi-solids, Solids and Packaging.

Aenova provides its customers with an extended portfolio of semisolids - creams, ointments, gels - , and non-sterile oral and topical liquid formulations including nasal sprays. The Aenova Group is one of the leading companies in the global pharmaceutical and healthcare industry. The group´s portfolio of services covers the entire value chain for the development and production of all the main dosage forms and product groups in the field of medicines and dietary supplements

Aenova provides its customers with an extended portfolio of semisolids - creams, ointments, gels -, and non-sterile oral and topical liquid formulations including nasal sprays. The Aenova Group is one of the leading companies in the global pharmaceutical and healthcare industry. The group´s portfolio of services covers the entire value chain for the development and production of all the main dosage forms and product groups in the field of medicines and dietary supplements.

In our Center of Excellence for pharmaceutical soft capsules we apply decades of know-how and most modern infrastructure to provide impeccable quality to our customers worldwide. With our innate Swiss reliability we always deliver our products on time. Working hand in hand, our experienced team is passionate to find innovative solutions to challenging customer needs. Our high standards of service excellence are the driver for long-term, successful partnerships with our customers.

 The Aenova Group is one of the leading contract manufacturers for the pharmaceutical and healthcare industry. With high quality standards, innovative technologies and reliable delivery reliability Aenova has become the European CDMO market leader for the development and production of all common dosage forms and product groups in the business-to-business sector. The company, headquartered near Munich, operates 15 production facilities and several sales offices in ten countries around the world. More than 4,300 employees contribute to the group's success.